Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in American Indians

被引：0
|
作者：
Oestreich, J. [1 ]
Best, G. L. [2 ]
Crowe, B. W. [1 ]
Dobesh, P. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Turtle Mt Community Coll, Belcourt, ND USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：631 / 631
页数：1
相关论文
共 50 条
  • [1] Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in American Indians.
    Oestreich, Julie H.
    Best, Lyle G.
    Crowe, Brody W.
    Dobesh, Paul P.
    PHARMACOTHERAPY, 2013, 33 (10): : E231 - E231
  • [2] Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans
    Oestreich, Julie H.
    Best, Lyle G.
    Dobesh, Paul P.
    AMERICAN HEART JOURNAL, 2014, 167 (03) : 413 - 418
  • [3] Prevalence of CYP2C19 alleles, pharmacokinetic and pharmacodynamic variation of clopidogrel and prasugrel in Bangladeshi population
    Bin Sayeed, Muhammad Shahdaat
    Apu, Mohd Nazmul Hasan
    Munir, Maliha Tabassum
    Ahmed, Maizbha Uddin
    Islam, Mohammad Safiqul
    Haq, M. Maksumul
    Ahsan, Chowdhury H.
    Rashid, M. A.
    Shin, Jae Gook
    Hasnat, Abul
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (05) : 451 - 457
  • [4] FREQUENCY OF CYP2C19 VARIANT ALLELES IN KOREANS
    Hong, Seong-Kuk
    Choi, Min-Je
    Bae, Jung-Woo
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S87 - S87
  • [5] Clopidogrel dose adjustment after outpatient screening for CYP2C19 variant alleles: a pilot study
    Rossi, Joseph S.
    Cammarata, Michael
    Dharmavaram, Jayalalitha
    Weck, Karen
    Walko, Christine
    Gabriel, Don
    Kuritzky, Jack
    Muldrew, Kenneth
    Stouffer, George A.
    PHARMACOGENOMICS, 2014, 15 (07) : 915 - 923
  • [6] CYP2C19*2 polymorphism contributes to a diminished pharmacodynamic response to clopidogrel
    Brandt, JT
    Kirkwood, S
    Mukhopadhyay, N
    Payne, CD
    Salazar, D
    Ernest, CS
    Winters, KJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 380A - 380A
  • [7] Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy
    Tantray, Javeed Ahmad
    Reddy, K. Pratap
    Jamil, Kaiser
    Kumar, Y. Shiva
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 229 : 113 - 118
  • [8] The CYP2C19*17 variant is not independently associated with clopidogrel response
    Lewis, J. P.
    Stephens, S. H.
    Horenstein, R. B.
    O'Connell, J. R.
    Ryan, K.
    Peer, C. J.
    Figg, W. D.
    Spencer, S. D.
    Pacanowski, M. A.
    Mitchell, B. D.
    Shuldiner, A. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (09) : 1640 - 1646
  • [9] Clopidogrel increases risk of MACE in patients with CYP2C19 LoF alleles
    Reactions Weekly, 2025, 2047 (1) : 7 - 7
  • [10] Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians
    Bhat, Keshavamurthy Ganapathy
    Pillai, Ratheesh Kumar Janardhana
    Lodhi, Heemanshu
    Guleria, Vivek Singh
    Abbot, Anil Kumar
    Gupta, Love
    Rastogi, Garima
    Sharma, Anuka
    Mohammed, Zafar
    Sharma, Varun
    JOURNAL OF GENE MEDICINE, 2024, 26 (01):
12345